Palatin Technologies (PTN) EPS (Basic) (2010 - 2026)
Palatin Technologies' (PTN) quarterly EPS (Basic) came in at -$0.37 in Q1 2026, up 95.97% YoY from -$0.19 in Q1 2025, and up 87.19% on a QoQ basis from -$2.86 in Q4 2025.
Palatin Technologies (PTN) EPS (Basic) (2010 - 2026) Analysis & Trends
Palatin Technologies (PTN) has 17 years of EPS (Basic) data on file, last reported at -$0.37 in Q1 2026.
- Quarterly EPS (Basic) rose 95.97% year-over-year to -$0.37 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.6 (up 96.38% YoY) and the FY2025 annual result came in at -$105.66, down 4.45% from the prior year.
- EPS (Basic) improved to -$0.37 in Q1 2026, from -$2.86 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $4.81 in Q3 2025 to a low of -$66.89 in Q2 2022.
- A 5-year average of -$21.53 and a median of -$24.85 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2024 — EPS (Basic) slumped 1202.24% — and 2025, when it soared 124.82%.
- Tracing PTN's EPS (Basic) over 5 years: stood at -$30.74 in 2022, then rose by 9.51% to -$27.82 in 2023, then jumped by 77.48% to -$6.27 in 2024, then jumped by 54.36% to -$2.86 in 2025, then jumped by 87.19% to -$0.37 in 2026.
- The last three EPS (Basic) figures came in at -$0.37 (Q1 2026), -$2.86 (Q4 2025), and $4.81 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Palatin Technologies | 40.86 Mn | 40.86 Mn | - | -0.37 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.37 |
| Dec 31, 2025 | -2.86 |
| Sep 30, 2025 | 4.81 |
| Jun 30, 2025 | -2.71 |
| Mar 31, 2025 | -9.08 |
| Dec 31, 2024 | -6.27 |
| Sep 30, 2024 | -19.39 |
| Jun 30, 2024 | -28.07 |
| Mar 31, 2024 | -26.71 |
| Dec 31, 2023 | -27.82 |
| Sep 30, 2023 | -24.85 |
| Jun 30, 2023 | -2.16 |
| Mar 31, 2023 | -37.92 |
| Dec 31, 2022 | -30.74 |
| Sep 30, 2022 | -45.01 |
| Jun 30, 2022 | -66.89 |
| Mar 31, 2022 | -39.95 |
| Dec 31, 2021 | -45.57 |
| Sep 30, 2021 | -38.83 |
| Jun 30, 2021 | 14.71 |